Berlin Epilepsy Study

Recruiting

• Conditions: G40.9; Epilepsy, unspecified; R56.8; Other and unspecified convulsions

• Registration Number: DRKS00022454
• Lead Sponsor: Charité Universitätsmedizin Berlin; Klinik für Neurologie; Epilepsie-Zentrum Berlin -Brandenburg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-09-23
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 600

Inclusion Criteria

People with a first diagnosed epileptic seizure within the last three months (excluding former febrile seizures) who agree to participate in the study according to written informed consent, who are at least 14 yo and whose Primary residence is within Berlin/Brandenburg

Exclusion Criteria

1.) psychogenic non-epileptic seizures (additional or exclusive)
2.) cognitive impairment as well as severe organic disease, which compromise participation in the study
3.) relevant language barrier

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Occurrence of recurrent epileptic seizures, development of pharmacoresistence in case of antiseizure-medication, death/mortality riskwithin 5 yrs after the first epileptic seizure.<br>Identification of prognostic influencing variables.

Secondary Outcome Measures

Name	Time	Method
Occurrence of recurrent epileptic seizures, development of pharmacoresistence in case of antiseizure-medication, death/mortality risk in longterm-follow-up (>10 yrs) after the first epileptic seizure.<br>Identification of prognostic influencing variables.